ArticleOncoimmunology

In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial.

O Adotevi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.